CellCura ASA

FRA:C6L (Norway)  
€ 0.02 (0%) Feb 26
At Loss
Market Cap:
€ 130.00K ($ 141.00K)
Enterprise V:
€ 130.00K ($ 141.00K)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for CellCura ASA ( ) from 1990 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CellCura ASA stock (FRA:C6L) PE ratio as of Jun 04 2024 is 0. More Details

CellCura ASA (FRA:C6L) PE Ratio (TTM) Chart

To

CellCura ASA (FRA:C6L) PE Ratio (TTM) Historical Data

Total 0
  • 1
CellCura ASA PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

CellCura ASA (FRA:C6L) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.